1. Home
  2. Analysis
  3. Copaxone
  4. Lysine

Copaxone and Lysine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copaxone (glatiramer acetate) and Lysine (lysine). Common drug interactions include injection site reaction among females.

The phase IV clinical study analyzes what interactions people have when they take Copaxone and Lysine. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Lysine?

Lysine has active ingredients of lysine. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 16,524 Lysine users. Check the latest studies of Lysine.

On Jul, 19, 2026

23 people who take Copaxone and Lysine together, and have interactions are studied.

Copaxone and Lysine drug interactions.

What are the common drug interactions of Copaxone and Lysine, by gender? *:

female:

  1. Injection site reaction
  2. Fall
  3. Alopecia (absence of hair from areas of the body)
  4. Back pain
  5. Chills (felling of cold)
  6. Dizziness
  7. Heat exhaustion (dizziness and nausea and weakness caused by depletion of body fluids and electrolytes)
  8. Memory impairment
  9. Nausea (feeling of having an urge to vomit)
  10. Non-cardiac chest pain

male:

n/a

What are the common drug interactions of Copaxone and Lysine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Influenza like illness
  2. Injection site reaction

30-39:

n/a

40-49:

  1. Anxiety
  2. Balance disorder
  3. Gait disturbance
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Ligament sprain (ligament stretched)
  6. Laryngitis (inflammation of the larynx)

50-59:

  1. Injection site reaction
  2. Chills (felling of cold)
  3. Nausea (feeling of having an urge to vomit)
  4. Conjunctivitis (pink eye)
  5. Dry eye (lack of adequate tears)
  6. Eye disorder
  7. Eye irritation
  8. Eye pain
  9. Eyelid oedema (eyelids are swollen and contain excessive fluid)
  10. Injection site erythema (redness at injection site)

60+:

  1. Fall
  2. Fatigue (feeling of tiredness)
  3. Depersonalisation
  4. Diarrhoea
  5. Disturbance in attention
  6. Drug ineffective
  7. Energy increased
  8. Gait disturbance
  9. Gingival abscess (pus in gums)
  10. Gingival pain (gum pain)

What are the existing conditions these people have? *

  1. Gait Disturbance: 4 people, 17.39%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and Lysine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Copaxone and Lysine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Copaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lysine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Copaxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lysine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on glatiramer acetate and lysine (the active ingredients of Copaxone and Lysine, respectively), and Copaxone and Lysine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.